Congress Day 1

• Closing the Gap to TB Elimination: Roadmap from Control to Pre-Elimination
  Diego SilvaAssoc. Prof. Dr Speaker Australia
• Drug-Resistant Tuberculosis in Malaysia: From Injectable Regimens to All-Oral Therapy
  Mat Zuki Mat JaebDato' Dr Speaker Malaysia
• From Control to Elimination: Evaluating Malaysia’s Tuberculosis Journey and Future Priorities
  Zamzurina Abu BakarDr Speaker Malaysia
• Q&A

• Phenotyping in Bronchiectasis
  James ChalmersProf. Dr Speaker United Kingdom
• Therapeutic Advances in Bronchiectasis
  Anne ChangProf. Dr Speaker Australia
• Co-morbidities in Bronchiectasis
  Herbert Wang Chun KwokProf. Dr Speaker Hong Kong
• Q&A

• A New Horizon in ILD Treatment: Looking Beyond Nintedanib and Pirfenidone
  Ganesh RaghuProf. Dr Speaker United States
• Approach to Evaluation and Management of ILA
  Jin Woo SongProf. Dr Speaker Republic of Korea
• The 2025 ATS/ERS Classification and Implications in Clinical Practice
  Yasuhiko NishiokaProf. Dr Speaker Japan
• Q&A

• Achieving Asthma Remission in Resource-Limited Settings: Practical Strategies Beyond Biologics
  Azza OmarDr Speaker Malaysia
• Biomarker-directed Treatment of Acute Exacerbations of Asthma
  Anthony YiiClin. Asst. Prof. Speaker Singapore
• Predicting & Personalising: The Future of Asthma from Remission to Cure
  Peter GibsonProf. Dr Speaker Australia
• Q&A

• The Global Spectrum of Respiratory Diseases Caused by Exposure to Mineral Dusts in the Workplace
  Benoit NemeryProf. Dr Speaker Belgium
• Introduction of Anti-fibrotics Treatment in Combined Fibrosis and Pneumoconiosis and Prerequisites for Field Application
  Jun-Pyo MyongAssoc. Prof. Dr Speaker Republic of Korea
• Occupational Lung Diseases in Malaysia
  Siti Munira YasinProf. Dr Speaker Malaysia
• Q&A

• AI Radiomics for the Early Detection of Lung Cancer
  Ren YuanClin. Assoc. Prof. Dr Speaker Canada
• Overview of Lung Cancer in the Asia Pacific. Is It Different from Its Counterpart from Outside Asia?
  Chong Kin LiamEmeritus Prof. Dr Speaker Malaysia
• New Challenges of Lung Cancer Management in the Asian Pacific Region
  Yuh-Min ChenProf. Dr Speaker Taiwan
• Q&A

• Climate Change, Air Pollution and Respiratory Diseases
• Phenotypes of Childhood Wheeze: A Trajectory Analysis
  Takao FujisawaDr Speaker Japan
• The Progression from Infant Wheezing to Asthma in Children: Modern Data Approaches
  Jessie Anne De BruyneDr Speaker Malaysia
• Q&A

• Covid-19/Influenzae
  Angela BrancheDr Speaker United States
• Pneumococcal Vaccination
  Kazuko YamamotoDr Speaker Japan
• Respiratory Syncytial Virus
  Philip EngProf. Dr Speaker Singapore
• Q&A

• Unravelling the Mystery: Updates in the Classification of chILD
  Anna Marie NathanProf. Dr Speaker Malaysia
• How Do We Manage chILD in 2026?
• A Registry for chILD – Experience Sharing from Europe
• Q&A

• Obesity and Sleep Apnoea: Beyond Airway Obstruction
  Ahmad Izuanuddin IsmailProf. Dr Speaker Malaysia
• Obesity Hypoventilation Syndrome: Still the Forgotten Disorder?
  Yizhong ZhengDr Speaker Australia
• Integrating Weight Management into Sleep (Respiratory) Practice: From Passive Advice to Active Intervention
  Brendon YeeProf. Dr Speaker Australia
• Q&A

• Building a Truly Global Evidence Base: Capitalising Asian Diversity in Respiratory Research
  Michelle GongDr Speaker United States
• Asian Diversity and Personalised Respiratory Medicine Worldwide: Challenges and Solutions
  Shigeo MuroProf. Dr Speaker Japan
• From Equity to Partnership: Transforming Global Respiratory Research Collaborations
  Marc MiravitllesDr Speaker Spain
• Q&A